title: Hyperglycemia after intratympanic dexamethasone treatment in a diabetic patient.
abstract: The treatment of patients with idiopathic sudden sensorineural hearing loss must be performed as an emergency measure in order to prevent long term hearing deficit. Steroids in monotherapy provide the best outcome. There is some controversy regarding the most efficient route but in order to prevent side effects, intratympanic treatment is the preferred choice, especially in diabetic patients. We here present the case of a patient that developed hyperglycemia after systemic and intratympanic dexamethasone treatment for sudden hearing loss. We conclude that after intratympanic treatment great caution must be taken.
authors.affiliation: Clínica Universidad de Navarra, Dpto. de ORL, Pío XII 36, 31008 Pamplona Navarra, Spain.
authors.forename: V
authors.initials: V
authors.lastname: Gallegos-Constantino
authors.forename: F J
authors.initials: FJ
authors.lastname: Cervera-Paz
authors.forename: J
authors.initials: J
authors.lastname: Salvador
authors.forename: F K
authors.initials: FK
authors.lastname: Ba
authors.forename: N
authors.initials: N
authors.lastname: Perez-Fernandez
mesh_terms: D001301:Audiometry, Pure-Tone; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy*; D003639:Hearing Loss, Sudden / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000188:drug therapy; D008845:Microinjections; D008875:Middle Aged; D012008:Recurrence; D016896:Treatment Outcome; D014432:Tympanic Membrane / Q000187:drug effects*
chemical_list: D005938:Glucocorticoids; D003907:Dexamethasone